Trial Profile
Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle or Resection Cavity in Children and Adults With Recurrent Posterior Fossa Ependymoma: A Phase I Study
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Ependymoma
- Focus Adverse reactions
- 17 Aug 2022 Planned End Date changed from 1 Jul 2022 to 1 Dec 2023.
- 17 Aug 2022 Planned primary completion date changed from 1 Jul 2022 to 1 Dec 2023.
- 02 Nov 2020 Planned End Date changed from 1 Jul 2020 to 1 Jul 2022.